View Financial HealthBiokarpet 배당 및 자사주 매입배당 기준 점검 0/6Biokarpet 은(는) 현재 수익률이 1.22% 인 배당금 지급 회사입니다. 다음 지급일은 28th August, 2026 이며 배당락일은 다음과 같습니다. 24th August, 2026.핵심 정보1.2%배당 수익률1.2%자사주 매입 수익률총 주주 수익률2.4%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일28 Aug 26배당락일24 Aug 26주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트Declared Dividend • May 31Dividend increased to €0.03Dividend of €0.03 is 50% higher than last year. Ex-date: 24th August 2026 Payment date: 28th August 2026 Dividend yield will be 1.8%, which is lower than the industry average of 4.8%. Sustainability & Growth The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years.Upcoming Dividend • Aug 18Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 25 August 2025. Payment date: 29 August 2025. Trailing yield: 1.0%. Lower than top quartile of Greek dividend payers (4.6%). Lower than average of industry peers (3.7%).Upcoming Dividend • Aug 19Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 26 August 2024. Payment date: 30 August 2024. The average dividend yield among industry peers is 4.3%.Upcoming Dividend • Aug 21Inaugural dividend of €0.015 per shareEligible shareholders must have bought the stock before 28 August 2023. Payment date: 01 September 2023. This is the first dividend for Biokarpet since going public. The average dividend yield among industry peers is 8.8%.모든 업데이트 보기Recent updatesDeclared Dividend • May 31Dividend increased to €0.03Dividend of €0.03 is 50% higher than last year. Ex-date: 24th August 2026 Payment date: 28th August 2026 Dividend yield will be 1.8%, which is lower than the industry average of 4.8%. Sustainability & Growth The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years.New Risk • May 06New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 13% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€38.7m market cap, or US$45.6m).New Risk • Apr 13New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (€38.8m market cap, or US$45.5m).공시 • Feb 20Biokarpet S.A., Annual General Meeting, May 27, 2026Biokarpet S.A., Annual General Meeting, May 27, 2026.분석 기사 • Oct 24Capital Allocation Trends At Biokarpet (ATH:BIOKA) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...분석 기사 • Sep 05Some Shareholders Feeling Restless Over Biokarpet S.A.'s (ATH:BIOKA) P/S RatioThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-sales (or "P/S") ratio of 0.2x is worth a...Upcoming Dividend • Aug 18Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 25 August 2025. Payment date: 29 August 2025. Trailing yield: 1.0%. Lower than top quartile of Greek dividend payers (4.6%). Lower than average of industry peers (3.7%).New Risk • Jul 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 5.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Share price has been highly volatile over the past 3 months (5.7% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€43.4m market cap, or US$50.7m).New Risk • Jun 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 312% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.8x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€40.9m market cap, or US$46.4m).New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 2.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€41.7m market cap, or US$47.1m).분석 기사 • Apr 24Return Trends At Biokarpet (ATH:BIOKA) Aren't AppealingIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...New Risk • Apr 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (€37.1m market cap, or US$42.2m).New Risk • Mar 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 4.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (4.4% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€41.5m market cap, or US$43.0m).분석 기사 • Feb 28Biokarpet S.A. (ATH:BIOKA) Investors Are Less Pessimistic Than ExpectedThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 12.5x is worth a...공시 • Feb 19Biokarpet S.A., Annual General Meeting, Jun 18, 2025Biokarpet S.A., Annual General Meeting, Jun 18, 2025.공시 • Dec 25Biokarpet S.A.(ATSE:BIOKA) dropped from ATHEX Composite IndexBiokarpet S.A. has been dropped from the ATHEX Composite Index.분석 기사 • Oct 07We Think That There Are More Issues For Biokarpet (ATH:BIOKA) Than Just Sluggish EarningsThe market wasn't impressed with the soft earnings from Biokarpet S.A. ( ATH:BIOKA ) recently. Our analysis has found...New Risk • Oct 07New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Share price has been highly volatile over the past 3 months (6.4% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€39.1m market cap, or US$42.9m).분석 기사 • Oct 03Is Biokarpet (ATH:BIOKA) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Sep 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 6.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Share price has been highly volatile over the past 3 months (6.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (€44.6m market cap, or US$49.8m).공시 • Sep 01Biokarpet S.A. to Report First Half, 2024 Results on Sep 27, 2024Biokarpet S.A. announced that they will report first half, 2024 results on Sep 27, 2024Upcoming Dividend • Aug 19Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 26 August 2024. Payment date: 30 August 2024. The average dividend yield among industry peers is 4.3%.New Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Significant insider selling over the past 3 months (€644k sold). Market cap is less than US$100m (€47.3m market cap, or US$52.1m).New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.7x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€69.6m market cap, or US$73.9m).분석 기사 • Apr 13The Return Trends At Biokarpet (ATH:BIOKA) Look PromisingDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...공시 • Apr 01Biokarpet S.A. to Report Q4, 2023 Results on Apr 30, 2024Biokarpet S.A. announced that they will report Q4, 2023 results on Apr 30, 2024Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.67, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 10x in the Metals and Mining industry in Europe. Total returns to shareholders of 265% over the past three years.분석 기사 • Nov 09Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading HigherFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...분석 기사 • Oct 10Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Oct 05First half 2023 earnings released: EPS: €0.091 (vs €0.29 in 1H 2022)First half 2023 results: EPS: €0.091 (down from €0.29 in 1H 2022). Revenue: €118.3m (down 10.0% from 1H 2022). Net income: €2.18m (down 69% from 1H 2022). Profit margin: 1.8% (down from 5.3% in 1H 2022). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 50% per year, which means it is significantly lagging earnings growth.New Risk • Oct 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€53.0m market cap, or US$56.0m).Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €2.21, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 8x in the Metals and Mining industry in Greece. Total returns to shareholders of 252% over the past three years.Board Change • Sep 26No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.분석 기사 • Sep 09Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift SharesBiokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 7.4x might make it look like a buy right now...공시 • Sep 01Biokarpet S.A. to Report First Half, 2023 Results on Sep 29, 2023Biokarpet S.A. announced that they will report first half, 2023 results on Sep 29, 2023Upcoming Dividend • Aug 21Inaugural dividend of €0.015 per shareEligible shareholders must have bought the stock before 28 August 2023. Payment date: 01 September 2023. This is the first dividend for Biokarpet since going public. The average dividend yield among industry peers is 8.8%.분석 기사 • Jul 11Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-BaggerWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...공시 • Jun 01Biokarpet S.A., Annual General Meeting, Jun 21, 2023Biokarpet S.A., Annual General Meeting, Jun 21, 2023, at 11:00 E. Europe Standard Time. Location: LARISA, 5th KLM LARISA-ATHENS Athens GreeceValuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.08, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 285% over the past three years.분석 기사 • Mar 23Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share PriceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €1.94, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 55% over the past three years.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Sep 30First half 2022 earnings released: EPS: €0.29 (vs €0.072 in 1H 2021)First half 2022 results: EPS: €0.29 (up from €0.072 in 1H 2021). Revenue: €131.5m (up 46% from 1H 2021). Net income: €6.98m (up 305% from 1H 2021). Profit margin: 5.3% (up from 1.9% in 1H 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to €1.55, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 86% over the past three years.분석 기사 • Sep 14Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...공시 • Sep 02Biokarpet S.A. to Report First Half, 2022 Results on Sep 28, 2022Biokarpet S.A. announced that they will report first half, 2022 results on Sep 28, 2022분석 기사 • Jun 04Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...공시 • Jun 01Biokarpet S.A., Annual General Meeting, Jun 22, 2022Biokarpet S.A., Annual General Meeting, Jun 22, 2022, at 09:00 Coordinated Universal Time. Location: LARISA, 5th KLM LARISSA-ATHENS Athens GreeceReported Earnings • May 05Full year 2021 earnings released: EPS: €0.17 (vs €0.009 in FY 2020)Full year 2021 results: EPS: €0.17 (up from €0.009 in FY 2020). Revenue: €187.3m (up 52% from FY 2020). Net income: €4.21m (up €3.99m from FY 2020). Profit margin: 2.2% (up from 0.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • Apr 01Biokarpet S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022Biokarpet S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.35, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 135% over the past three years.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improved over the past weekAfter last week's 22% share price gain to €1.81, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 174% over the past three years.분석 기사 • Dec 09Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to €1.67, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 209% over the past three years.분석 기사 • Oct 21Is Biokarpet (ATH:BIOKA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Oct 01First half 2021 earnings released: EPS €0.072 (vs €0.10 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €90.1m (up 55% from 1H 2020). Net income: €1.72m (up €4.13m from 1H 2020). Profit margin: 1.9% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.분석 기사 • Jun 03Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Reported Earnings • Apr 28Full year 2020 earnings released: EPS €0.009 (vs €0.052 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €123.2m (down 2.0% from FY 2019). Net income: €218.8k (down 82% from FY 2019). Profit margin: 0.2% (down from 1.0% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Feb 23Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Is New 90 Day High Low • Dec 07New 90-day high: €0.81The company is up 19% from its price of €0.68 on 08 September 2020. The Greek market is up 17% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Metals and Mining industry, which is up 33% over the same period.Is New 90 Day High Low • Oct 27New 90-day high: €0.76The company is up 26% from its price of €0.60 on 29 July 2020. The Greek market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 5.0% over the same period.Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €1.83m, with earnings decreasing by €3.50m from the prior year. Total revenue was €115.7m over the last 12 months, down 9.6% from the prior year.공시 • Sep 06Biokarpet S.A. to Report First Half, 2020 Results on Sep 30, 2020Biokarpet S.A. announced that they will report first half, 2020 results on Sep 30, 2020예정된 배당 지급오늘Jul 10 2026배당락일Aug 24 2026배당 지급일Aug 28 20264 days (배당락일 기준)다음 배당금을 받으려면 앞으로 45 days일 이내에 매수하세요지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 이제 막 배당금 지급을 시작했기 때문에 BIOKA 의 배당금 지급이 안정적인지 여부를 판단하기에는 너무 이릅니다.배당금 증가: 이제 막 배당금 지급을 시작했기 때문에 BIOKA 의 배당금 지급액이 늘어나고 있는지 판단하기에는 너무 이릅니다.배당 수익률 vs 시장Biokarpet 배당 수익률 vs 시장BIOKA의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (BIOKA)1.2%시장 하위 25% (GR)2.1%시장 상위 25% (GR)4.9%업계 평균 (Metals and Mining)2.6%분석가 예측 (BIOKA) (최대 3년)n/a주목할만한 배당금: BIOKA 의 배당금( 1.22% )은 Greek 시장에서 배당금 지급자의 하위 25%( 2.08% )와 비교해 주목할 만하지 않습니다.고배당: BIOKA 의 배당금( 1.22% )은 Greek 시장에서 배당금 지급자의 상위 25%( 4.9% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 BIOKA 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: BIOKA 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YGR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/09 03:59종가2026/07/09 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Biokarpet S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Declared Dividend • May 31Dividend increased to €0.03Dividend of €0.03 is 50% higher than last year. Ex-date: 24th August 2026 Payment date: 28th August 2026 Dividend yield will be 1.8%, which is lower than the industry average of 4.8%. Sustainability & Growth The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years.
Upcoming Dividend • Aug 18Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 25 August 2025. Payment date: 29 August 2025. Trailing yield: 1.0%. Lower than top quartile of Greek dividend payers (4.6%). Lower than average of industry peers (3.7%).
Upcoming Dividend • Aug 19Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 26 August 2024. Payment date: 30 August 2024. The average dividend yield among industry peers is 4.3%.
Upcoming Dividend • Aug 21Inaugural dividend of €0.015 per shareEligible shareholders must have bought the stock before 28 August 2023. Payment date: 01 September 2023. This is the first dividend for Biokarpet since going public. The average dividend yield among industry peers is 8.8%.
Declared Dividend • May 31Dividend increased to €0.03Dividend of €0.03 is 50% higher than last year. Ex-date: 24th August 2026 Payment date: 28th August 2026 Dividend yield will be 1.8%, which is lower than the industry average of 4.8%. Sustainability & Growth The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years.
New Risk • May 06New major risk - Revenue and earnings growthEarnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 13% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€38.7m market cap, or US$45.6m).
New Risk • Apr 13New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin). Market cap is less than US$100m (€38.8m market cap, or US$45.5m).
공시 • Feb 20Biokarpet S.A., Annual General Meeting, May 27, 2026Biokarpet S.A., Annual General Meeting, May 27, 2026.
분석 기사 • Oct 24Capital Allocation Trends At Biokarpet (ATH:BIOKA) Aren't IdealTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
분석 기사 • Sep 05Some Shareholders Feeling Restless Over Biokarpet S.A.'s (ATH:BIOKA) P/S RatioThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-sales (or "P/S") ratio of 0.2x is worth a...
Upcoming Dividend • Aug 18Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 25 August 2025. Payment date: 29 August 2025. Trailing yield: 1.0%. Lower than top quartile of Greek dividend payers (4.6%). Lower than average of industry peers (3.7%).
New Risk • Jul 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 5.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Share price has been highly volatile over the past 3 months (5.7% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€43.4m market cap, or US$50.7m).
New Risk • Jun 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 312% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.8x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€40.9m market cap, or US$46.4m).
New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 2.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€41.7m market cap, or US$47.1m).
분석 기사 • Apr 24Return Trends At Biokarpet (ATH:BIOKA) Aren't AppealingIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
New Risk • Apr 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (€37.1m market cap, or US$42.2m).
New Risk • Mar 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 4.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (4.4% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€41.5m market cap, or US$43.0m).
분석 기사 • Feb 28Biokarpet S.A. (ATH:BIOKA) Investors Are Less Pessimistic Than ExpectedThere wouldn't be many who think Biokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 12.5x is worth a...
공시 • Feb 19Biokarpet S.A., Annual General Meeting, Jun 18, 2025Biokarpet S.A., Annual General Meeting, Jun 18, 2025.
공시 • Dec 25Biokarpet S.A.(ATSE:BIOKA) dropped from ATHEX Composite IndexBiokarpet S.A. has been dropped from the ATHEX Composite Index.
분석 기사 • Oct 07We Think That There Are More Issues For Biokarpet (ATH:BIOKA) Than Just Sluggish EarningsThe market wasn't impressed with the soft earnings from Biokarpet S.A. ( ATH:BIOKA ) recently. Our analysis has found...
New Risk • Oct 07New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Share price has been highly volatile over the past 3 months (6.4% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€39.1m market cap, or US$42.9m).
분석 기사 • Oct 03Is Biokarpet (ATH:BIOKA) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Sep 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Greek stocks, typically moving 6.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Share price has been highly volatile over the past 3 months (6.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Market cap is less than US$100m (€44.6m market cap, or US$49.8m).
공시 • Sep 01Biokarpet S.A. to Report First Half, 2024 Results on Sep 27, 2024Biokarpet S.A. announced that they will report first half, 2024 results on Sep 27, 2024
Upcoming Dividend • Aug 19Upcoming dividend of €0.02 per shareEligible shareholders must have bought the stock before 26 August 2024. Payment date: 30 August 2024. The average dividend yield among industry peers is 4.3%.
New Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.2x net interest cover). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.6% net profit margin). Significant insider selling over the past 3 months (€644k sold). Market cap is less than US$100m (€47.3m market cap, or US$52.1m).
New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.7x net interest cover). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€69.6m market cap, or US$73.9m).
분석 기사 • Apr 13The Return Trends At Biokarpet (ATH:BIOKA) Look PromisingDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
공시 • Apr 01Biokarpet S.A. to Report Q4, 2023 Results on Apr 30, 2024Biokarpet S.A. announced that they will report Q4, 2023 results on Apr 30, 2024
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.67, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 10x in the Metals and Mining industry in Europe. Total returns to shareholders of 265% over the past three years.
분석 기사 • Nov 09Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading HigherFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Oct 10Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Oct 05First half 2023 earnings released: EPS: €0.091 (vs €0.29 in 1H 2022)First half 2023 results: EPS: €0.091 (down from €0.29 in 1H 2022). Revenue: €118.3m (down 10.0% from 1H 2022). Net income: €2.18m (down 69% from 1H 2022). Profit margin: 1.8% (down from 5.3% in 1H 2022). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 50% per year, which means it is significantly lagging earnings growth.
New Risk • Oct 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.9x net interest cover). Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€53.0m market cap, or US$56.0m).
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €2.21, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 8x in the Metals and Mining industry in Greece. Total returns to shareholders of 252% over the past three years.
Board Change • Sep 26No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
분석 기사 • Sep 09Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift SharesBiokarpet S.A.'s ( ATH:BIOKA ) price-to-earnings (or "P/E") ratio of 7.4x might make it look like a buy right now...
공시 • Sep 01Biokarpet S.A. to Report First Half, 2023 Results on Sep 29, 2023Biokarpet S.A. announced that they will report first half, 2023 results on Sep 29, 2023
Upcoming Dividend • Aug 21Inaugural dividend of €0.015 per shareEligible shareholders must have bought the stock before 28 August 2023. Payment date: 01 September 2023. This is the first dividend for Biokarpet since going public. The average dividend yield among industry peers is 8.8%.
분석 기사 • Jul 11Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-BaggerWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
공시 • Jun 01Biokarpet S.A., Annual General Meeting, Jun 21, 2023Biokarpet S.A., Annual General Meeting, Jun 21, 2023, at 11:00 E. Europe Standard Time. Location: LARISA, 5th KLM LARISA-ATHENS Athens Greece
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.08, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 285% over the past three years.
분석 기사 • Mar 23Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share PriceIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...
Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €1.94, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 55% over the past three years.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Sep 30First half 2022 earnings released: EPS: €0.29 (vs €0.072 in 1H 2021)First half 2022 results: EPS: €0.29 (up from €0.072 in 1H 2021). Revenue: €131.5m (up 46% from 1H 2021). Net income: €6.98m (up 305% from 1H 2021). Profit margin: 5.3% (up from 1.9% in 1H 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to €1.55, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 3x in the Metals and Mining industry in Greece. Total returns to shareholders of 86% over the past three years.
분석 기사 • Sep 14Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
공시 • Sep 02Biokarpet S.A. to Report First Half, 2022 Results on Sep 28, 2022Biokarpet S.A. announced that they will report first half, 2022 results on Sep 28, 2022
분석 기사 • Jun 04Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
공시 • Jun 01Biokarpet S.A., Annual General Meeting, Jun 22, 2022Biokarpet S.A., Annual General Meeting, Jun 22, 2022, at 09:00 Coordinated Universal Time. Location: LARISA, 5th KLM LARISSA-ATHENS Athens Greece
Reported Earnings • May 05Full year 2021 earnings released: EPS: €0.17 (vs €0.009 in FY 2020)Full year 2021 results: EPS: €0.17 (up from €0.009 in FY 2020). Revenue: €187.3m (up 52% from FY 2020). Net income: €4.21m (up €3.99m from FY 2020). Profit margin: 2.2% (up from 0.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. No independent directors (6 non-independent directors). Executive Director Panagiotis Mauromatis was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • Apr 01Biokarpet S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022Biokarpet S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.35, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 135% over the past three years.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment improved over the past weekAfter last week's 22% share price gain to €1.81, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 174% over the past three years.
분석 기사 • Dec 09Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to €1.67, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 5x in the Metals and Mining industry in Greece. Total returns to shareholders of 209% over the past three years.
분석 기사 • Oct 21Is Biokarpet (ATH:BIOKA) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Oct 01First half 2021 earnings released: EPS €0.072 (vs €0.10 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €90.1m (up 55% from 1H 2020). Net income: €1.72m (up €4.13m from 1H 2020). Profit margin: 1.9% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth.
분석 기사 • Jun 03Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Reported Earnings • Apr 28Full year 2020 earnings released: EPS €0.009 (vs €0.052 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €123.2m (down 2.0% from FY 2019). Net income: €218.8k (down 82% from FY 2019). Profit margin: 0.2% (down from 1.0% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Feb 23Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Is New 90 Day High Low • Dec 07New 90-day high: €0.81The company is up 19% from its price of €0.68 on 08 September 2020. The Greek market is up 17% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Metals and Mining industry, which is up 33% over the same period.
Is New 90 Day High Low • Oct 27New 90-day high: €0.76The company is up 26% from its price of €0.60 on 29 July 2020. The Greek market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Metals and Mining industry, which is up 5.0% over the same period.
Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €1.83m, with earnings decreasing by €3.50m from the prior year. Total revenue was €115.7m over the last 12 months, down 9.6% from the prior year.
공시 • Sep 06Biokarpet S.A. to Report First Half, 2020 Results on Sep 30, 2020Biokarpet S.A. announced that they will report first half, 2020 results on Sep 30, 2020